Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • Eleven Minutes
    • Priced Out
    • Data Grab
    • Memory Gaps
    • Growing Up Scared
    • Denied
    • Opioid Settlement Tracking
    • Guns, Race, and Profit
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email
  • Add Us to Google

Wednesday, Nov 18 2026 9:12 AM

KFF Health News Original Stories 2

  • Meet the Teen Who Called a Hospital Home
  • Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

Public Health 1

  • Once Hailed For Beating Measles, US Faces Long, Hard Road Back To Elimination Status

Pharma and Tech 1

  • Leukemia Vaccine Succeeds In Pivotal Trial

Administration News 1

  • White House Ends Heidi Overton's Chance At Leading FDA

Elections 1

  • With Peltola's Historic Win In Alaska, Democrats Close In On A Senate Supermajority

State Watch 1

  • Amid Midterm Momentum, Democrats In Georgia, Kansas, Texas Look Toward Medicaid Expansion

Health Industry 1

  • Financial Troubles Escalate At Illinois Hospital As State Denies $9M Request From Doctors

Editorials And Opinions 1

  • Viewpoints: First Political Battles Of 2027 Should Tackle Medicaid, RFK Jr. Impeachment; Measles Deaths Are A Preventable Tragedy

From KFF Health News - Latest Stories:

KFF Health News Original Stories

Meet the Teen Who Called a Hospital Home

A young survivor of gun violence lived on the third floor of a St. Louis children’s hospital, moving through the halls in a wheelchair, on and off for over three years. He said it became his home when he had nowhere safe to go. ( Cara Anthony , 11/18 )

Trump Administration OKs Native Traditional Healing for Two States’ Medicaid Programs

The administration’s expansion of traditional healing for Native Americans comes as it shrinks Medicaid in other ways, including through restrictions that will affect access to care for an estimated 7.5 million people. ( Jazmin Orozco Rodriguez , 11/18 )

Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Here's today's health policy haiku:

WHAT WE'RE UP AGAINST

The best medicine
can't cure an anti-science
algorithmic feed.

— Chris Goins

If you have a health policy haiku to share, please Contact Us and let us know if we can include your name. Haikus follow the format of 5-7-5 syllables. We give extra brownie points if you link back to an original story.

Opinions expressed in haikus are solely the author's and do not reflect the opinions of KFF Health News or KFF.

Summaries Of The News:

Public Health

Once Hailed For Beating Measles, US Faces Long, Hard Road Back To Elimination Status

The United States once served as a shining example of what is possible when public health experts put in the work to eradicate, or at least contain, an infectious disease. Now, they have to start at the beginning again and convince an increasingly doubting public that vaccines are the best way to protect everyone — especially the littlest among us who can't get a shot — from the death and disability caused by measles. That could "take a lot of small coffins in the ground,” one expert told The New York Times.
The New York Times: U.S. Loses Its Measles Elimination Status, A Historic Setback For American Health 

Measles has come roaring back in the United States, as vaccination rates have fallen and cases of the once-extinguished virus have soared. That backslide has now cost the nation its measles elimination status, after the virus spread uninterrupted for more than a year. “It’s a giant stain on our reputation,” said Jennifer Nuzzo, director of the Pandemic Center at the Brown University School of Public Health. “Everyone ought to be just utterly disgusted by the willing return back to an age of death and high cost.” (Rosenbluth, 11/17)

The Hill: Robert F. Kennedy Jr. Vows To Regain U.S. Measles Elimination Status

Health and Human Services (HHS) Robert F. Kennedy Jr. said on Tuesday that the U.S. will “work to regain” its measles elimination status after officially losing it. “We will stop measles outbreaks, protect American families, and work to regain U.S. measles elimination status. I continue to recommend MMR vaccination as the most effective way to prevent measles,” Kennedy said in a Tuesday afternoon post to the social platform X. (Suter, 11/17)

The Wall Street Journal: Measles Is Back. It Will Take Years To Eliminate It Again. 

The U.S.’s loss of what is known as measles-elimination status is a massive public-health defeat that begs a question: How long will it take to regain it? Based on other countries’ experience it could be up to five years, say doctors and epidemiologists. But that assumes the federal government is a robust and willing participant proactively working on measles vaccination. (Reddy, 11/18)

Reactions from lawmakers and public health experts —

The Hill: Democrats Blast Trump Administration Over Loss Of Measles Elimination Status

In a Monday statement, Sen. Ron Wyden (D-Ore.) said the loss of the elimination status “is the tragic yet predictable result of an ongoing campaign by grifters, quacks and charlatans to put their own greed and self-worth ahead of the health and safety of children.” Sen. Michael Bennet (D-Colo.) in a statement called on CDC Director Erica Schwartz to resign, accusing her of offering “excuses and complacency” rather than mounting an urgent response to protect children. In the House, the Democratic Doctors Caucus said the decision to remove measles elimination status was “directly linked to the doubt and misinformation that HHS [Health and Human Services] Secretary Robert F. Kennedy Jr. has spread surrounding vaccines.” (Suter, 11/17)

MPR News: U.S. Rep. Kelly Morrison Calls For Robert F. Kennedy Jr.’s Resignation 

Minnesota has logged 160 cases so far this year. “This is devastating news,” said Rep. Kelly Morrison, who represents Minnesota’s 3rd Congressional District. The Congresswoman is part of Democratic Doctors Caucus, which is demanding accountability for Health and Human Services Secretary Robert F. Kennedy Jr. due to his stance on vaccines. “Kennedy has really profited off of his campaign of misinformation for years before the president appointed him to lead our biggest public health organizations,” Morrison said. (Masters, Jabbour and Alvarez, 11/17)

Newsweek: Michael Bloomberg Slams Trump Admin as US Loses Measles Elimination Status

Former New York City mayor and public health philanthropist Michael Bloomberg condemned President Donald Trump administration’s handling of a resurgence that has infected more than 5,400 Americans. “The U.S. losing its status as a nation that has eliminated measles is a damning indictment of federal health leadership,” Bloomberg posted on X on Tuesday morning. (Skinner, 11/17)

The Guardian: ‘I’m Heartbroken’: Experts Dismayed As US Loses Long-Held Measles Elimination Status

“There’s no question it was emotional, because we’ve been working on this initiative for decades,” Dr Jon Andrus, the chair of the Paho advisory committee that recommended the US lose its measles elimination status, told the Guardian. “To see the US, once a global leader, lose its status is of course sad,” Andrus continued, citing the work of friends and colleagues, “and it was also sad to see our Mexican colleagues lose their status, as well as Bolivia.” (Glenza, 11/18)

What this means for you —

The Washington Post: Four Ways The U.S. Measles Status Could Affect You

Ordinary activities may take on new risks for certain vulnerable populations because there isn’t widespread community immunity to protect those who can’t get vaccinated: young babies, pregnant women and people with weakened immune systems. Megan Ranney, an emergency room physician and dean of Yale’s School of Public Health, said in communities where measles is spreading, parents may have to reconsider whether they want to take infants too young to be vaccinated to family gatherings, restaurants, groceries stores and trains and planes. (Sun, 11/17)

The New York Times: Measles Is Officially Back In The United States. What Now?

Local and state health departments will need more resources to combat outbreaks. Doctors, parents and teachers will need to familiarize themselves with the symptoms, and prepare to quarantine anyone who is unvaccinated and exposed for 21 days. Hospitals will need to prepare for an onslaught of patients infected with a highly contagious virus. Public health officials may need new tools to detect, diagnose and stem outbreaks quickly. And they may need to revise the recommended vaccination schedule to protect the most vulnerable. (Mandavilli and Blum, 11/17)

CNN: Who Should Get A Booster? 

The CDC considers adults born before 1957 to be immune to measles, essentially because, before the vaccine, nearly every child caught the virus at some point. A single dose of the measles-mumps-rubella vaccine is considered 93% effective at preventing measles. In fact, only one dose was recommended until 1989, when the US government changed the recommendation to two doses after a measles outbreak among vaccinated school-age children. Two doses of MMR boost measles protection to 97%. If you were vaccinated before 1989 and did not receive a second shot, you may want to consider getting one now. If you don’t know whether you were vaccinated as a child or whether you have been fully vaccinated, talk to your healthcare provider, who may want to give you another shot. (Christensen, 11/17)

CIDRAP: As Measles Cases Mount, New Report Highlights Safety Of Early Vaccination For Infants

As Americans prepare for holiday travel amid a nationwide measles resurgence and diminished federal public health communications, a new paper from the Center for Infectious Disease Research and Policy’s (CIDRAP’s) Vaccine Integrity Project (VIP) at the University of Minnesota highlights data showing that infants as young as 6 months can safely receive the measles, mumps, and rubella (MMR) vaccine. CIDRAP is the publisher of CIDRAP News. (Bergeson, 11/17)

Where measles is spreading —

NBC News: As US Loses Measles Elimination Status, See A Map Of States With The Most Cases

Measles, a vaccine-preventable disease once considered eliminated in the United States, has been surging across the country in recent months. Amid record-breaking outbreaks, the U.S. has officially lost its measles elimination status, which it held for over 26 years. (Kee, 11/17)

The New York Times: 26 More Measles Cases In New York, But Outbreak Appears To Be Easing 

The measles outbreak that has moved through several Amish settlements in upstate New York is showing signs of slowing slightly, according to new data from the State Department of Health. Health authorities in the past week have recorded 26 additional cases, according to figures released on Tuesday — the same day that the United States lost its longtime designation as a nation that had vanquished measles. The ongoing outbreak is the most significant in New York State since hundreds of cases were recorded in New York City and elsewhere in the state in 2018 and 2019. (Goldstein, 11/17)

Axios: Pennsylvania's Growing Costs To Contain Measles Outbreak

Pennsylvania's measles outbreak has cost at least $16.9 million in public funding, according to a new Johns Hopkins University analysis. (D'Onofio and Bettelheim, 11/18)

Cardinal News: Virginia Health Department Confirms Measles Case In Central Virginia 

The Virginia Department of Health confirmed another measles case Tuesday, the same day that an international health organization announced that the virus is no longer considered to be eliminated in the United States. (Schabacker, 11/18)

Pharma and Tech

Leukemia Vaccine Succeeds In Pivotal Trial

The trial showed a 41% reduction in risk of death for patients with acute myeloid leukemia patients who received the galinpepimut-S (GPS) vaccine, The Washington Post reported. Plus, the FDA anticipates the safety review of the abortion pill mifepristone to be finished by March.
The Washington Post: Leukemia Vaccine Passes Key Trial, Adding To Breakthrough Year For Cancer Drugs

A first of its kind vaccine for acute myeloid leukemia, a deadly blood cancer, succeeded in a Phase 3 clinical trial, drugmaker Sellas Life Sciences and Memorial Sloan Kettering Cancer Center announced Tuesday, marking another positive result in a breakthrough year for cancer vaccines. (Wu, 11/17)

On the abortion pill —

Bloomberg: Abortion Pill Mifepristone Safety Review By FDA Set For March 2027 Completion

US health officials anticipate they will complete a report on the safety of the abortion drug mifepristone by next March, according to an update on the Food and Drug Administration’s website Tuesday. The FDA is using claims data from federal and private health insurance plans to compare the safety of mifepristone use, in combination with another drug called misoprostol, to surgical abortion. The agency expects to obtain the results from its analysis next month. (Edney, 11/17)

More pharma and tech developments —

MedPage Today: FDA Wants Liquid Statin Off Shelves

The FDA wants a liquid formulation of simvastatin (FloLipid) withdrawn from the market, though the agency is giving the drugmaker an opportunity for a hearing. Approval of simvastatin oral suspension is at risk because Salerno Pharma "has repeatedly failed to file required annual reports" to the FDA, according to a notice in the Federal Register. (Lou, 11/17)

The New York Times: Fearing Chinese Rivals, U.S. Biotech Adopts A New Norm: Share Nothing

It used to be that companies and scientists with ideas for new drugs couldn’t wait to announce their discoveries at meetings, in preprints and on their websites. That is changing. Researchers at the biotechnology firm Alnylam Pharmaceuticals have an unwritten policy: Do not reveal early-stage studies or discuss unpublished data, according to its founding chief executive, Dr. Christoph Westphal. (Kolata, 11/17)

Stat: New Startup Wants To Treat Sickle Cell Anemia Without Gene Therapy 

For years, researchers and investors have been searching for a treatment that’s as effective in treating sickle cell disease as gene therapy — but without the many drawbacks. Biotech entrepreneur Romesh Subramanian thinks he might have one. (Mast, 11/17)

The New York Times: What Can Genes Reveal About Chronic Pain?

Nearly everyone knows someone living with chronic pain. Yet this condition remains notoriously difficult to measure, explain or treat. It can follow an acute injury or arrive unprompted, often evading medical scans and leaving patients without the visible evidence that might convince others their pain is real. And doctors still struggle to understand why pain lingers indefinitely in some bodies and dissipates in others. (Baumgaertner Nunn, 11/17)

The New York Times: Does This Man Have A Right To The Data From His Own Brain?

On a recent Thursday, J. Galen Buckwalter drove 15 minutes from his home to the California Institute of Technology, steered his wheelchair into a laboratory and, as he had twice a week for two years, plugged in his brain. More precisely, he allowed a researcher to attach wires to three metal knobs screwed into his skull like a cyberpunk mohawk. The wires connect to six chips that were implanted in his brain during a seven-hour craniotomy. They record his neural signals — the firing of his brain when he thinks, speaks or moves — and transmit them to a computer to be analyzed. (Wang, 11/17)

Administration News

White House Ends Heidi Overton's Chance At Leading FDA

Senate health committee chairman Bill Cassidy, R-La., pushed back on the administration's conclusion that Overton lacked the support to be confirmed. “She would have had the votes to pass out of committee and pass the full Senate,” he wrote on social media. “My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk.”
The New York Times: White House Withdraws Nomination Of Heidi Overton To Be F.D.A. Commissioner

The White House has pulled the nomination of Dr. Heidi Overton to be commissioner of the Food and Drug Administration, on the eve of a crucial vote on her confirmation by a Senate panel, according to two people familiar with the decision. Dr. Overton, a White House domestic policy adviser who has been involved in developing some of the administration’s most controversial health policies, would have needed every Republican vote on the Senate health committee to advance her nomination to the Senate floor. It became clear to the White House on Tuesday night that she did not have enough votes. (Jewett, 11/17)

On veterans' healthcare —

Military Times: Nominee For Navy Secretary Addresses Suicide Prevention, Extended Deployments During Hearing

The nominee for Navy secretary faced questions from lawmakers Tuesday about sailors’ mental health, prolonged deployments and the service’s failure to notify Congress about the removal of a submarine’s command team. Before a Senate Armed Services Committee confirmation hearing, Acting Navy Secretary Hung Cao emphasized his commitment to providing adequate mental health resources to service members as the service continues to extend the time sailors are at sea. “I have done deployments to Iraq, Afghanistan, Somalia,” Cao said. “I understand what our sailors and Marines are going through and I put mental health at the top of my concern.” (Ceder, 11/17)

Military.com: Most Military Retirees Will See Medicare Costs Increase In 2027

Most Medicare enrollees will see their monthly premiums increase by 3.2% for 2027. That means Medicare users will generally pay $209.40 monthly, a $6.50 increase from the 2026 monthly premium of $202.90 — a 9.7% increase at the time. (Miller, 11/17)

Military Times: VA Crackdown On Fraud Results In Dozens Of Arrests  

Increased coordination between the Veterans Affairs and Justice departments to crack down on fraud has resulted in dozens of arrests in the past three months of individuals who allegedly scammed the VA out of nearly $20 million. Officials with the Justice Department’s National Fraud Enforcement Division, as well as U.S. Attorneys’ Offices and the VA Inspector General’s Office, announced Tuesday that a federal effort to address fraud in government benefits programs resulted in charges being brought against 15 people responsible for funneling $3.4 million from the VA and veterans. (Kime, 11/17)

STLPR: VA To Push Ahead With Health Records Upgrades Despite Concerns 

U.S. Department of Veterans Affairs officials were in St. Louis on Tuesday to meet with providers about the agency’s long-delayed effort to modernize its decades-old digital health records system. The message from VA leadership: The rollout is moving ahead, and the agency wants to pick up the pace. (Fentem, 11/17)

Military Times: VA Works To Provide Stable Housing For Homeless Veterans As Overall Numbers Decline 

The Department of Veterans Affairs provided stable housing in fiscal 2026 to nearly 49,000 veterans who were homeless or at risk of losing their homes, according to the VA. The figure was lower than the number of veterans housed in fiscal 2025, which was 51,936, but it represents the second-highest number of veterans housed per year since 2019 — the equivalent of about 4,000 veterans moving every month into permanent quarters. (Kime, 11/17)

The War Horse: She Reported Her Sexual Assault. The Marine Corps Kicked Her Out

Marina was training at the Basic School in Quantico, Virginia, when she attended the Marine Corps Ball in November 2023. The annual celebration of the Corps’ birthday was supposed to be a night of revelry and camaraderie. Instead, Marina said, a lieutenant sexually assaulted her at knifepoint. (Rosenbaum, 11/17)

Elections

With Peltola's Historic Win In Alaska, Democrats Close In On A Senate Supermajority

Democrat Mary Peltola has become the first Alaska Native elected to the U.S. Senate. Her historic victory, announced Tuesday, was the final undecided Senate race of the midterm elections. Peltola's win means that Democrats now control 56 seats in the Senate. They need 60 votes — just four from across the aisle — to end a filibuster. Additionally, 67 votes are needed — a two-thirds majority, or constitutional supermajority — to override a presidential veto or to vote to convict in a Senate impeachment trial.
The 19th: Mary Peltola Will Be The First Alaska Native In The U.S. Senate

Democrat Mary Peltola flipped an Alaska U.S. Senate seat — and made history. She’s now set to be the first Alaska Native elected to the U.S. Senate and gives Democrats 56 seats in that chamber. (Panetta, 11/17)

Al Jazeera: Why Democrat Mary Peltola’s US Senate Win In Alaska Matters 

Democrat Mary Peltola's win brings Democrats closer to the magical two-thirds majority. They now hold 56 seats. They will still need Republican support on issues to secure the two-thirds majority needed to overturn a presidential veto in both chambers. A two-thirds vote in the Senate is needed to convict an official in an impeachment trial. The more seats Democrats hold, the fewer Republicans they need to win over to reach that threshold. (Habib, 11/18)

Politico: Kirsten Gillibrand Is Dreaming Of A Democratic Supermajority 

Kirsten Gillibrand is already looking for a path to a filibuster-proof 60. The Senate Democratic campaign chair, in an interview with POLITICO after last week’s sweeping wins, laid out the possibility of flipping seven more seats in 2028, when the party faces a more favorable map but could also face a referendum on their own leadership in Congress after two years in power. Such a feat would give Democrats a Senate supermajority capable of defeating GOP attempts to block major bills. Coupled with a presidential win and a House majority, it would give them a level of unilateral power in Washington unseen since 2010, when President Barack Obama signed major health care and financial regulation overhauls. (Carney, 11/14)

Yahoo News: Final 2026 Midterm Results: Every Race That Hasn't Been Called Yet — And Where Things Stand Right Now

Seven U.S. House races remain unresolved. Two are in Louisiana, where the top two finishers in the 5th and 6th Districts will meet in a Dec. 12 runoff. As of Tuesday night, Democrats hold narrow leads in lead in races for three Republican-held seats by a few hundred votes each. (Romano and Bebernes, 11/17)

More legislative news —

Bloomberg: El-Sayed Senator-Elect Of Michigan Asks Trump, RFK Jr. On Health Collaboration

Sen.-elect Abdul El-Sayed, a Democrat from Michigan, made appeals to President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. to work across the aisle on health policy. At a Bloomberg Government breakfast event Tuesday morning, El-Sayed said he’d like to work with Trump to implement a streamlined Medicare system that comes with no deductibles or co-pays for its insurers. (Banks and Alexander, 11/17)

Roll Call: Jeffries Puts Immigration Bill High On Democratic Priority List 

House Minority Leader Hakeem Jeffries is signaling Democrats will move quickly on immigration legislation when the party reclaims the House in January, while acknowledging it still has work to do in shaping its healthcare agenda. Jeffries, who is expected to secure his spot as the next speaker during a closed-door vote of the Democratic caucus Wednesday, identified immigration and health care as among the top priorities for the incoming majority during a Tuesday news conference. (Green, 11/17)

Stat: What Susan Collins' Election Loss Could Mean For Science Funding 

Over the past six months, science advocates have been consumed by the fight over a White House proposal to subject all federal research contracts to more political oversight. Thousands of scientists and organizations have decried the potential changes as fundamentally rewriting the rules of American science. (Oza and Wilkerson, 11/18)

State Watch

Amid Midterm Momentum, Democrats In Georgia, Kansas, Texas Look Toward Medicaid Expansion

States eyeing an expansion of Medicaid, which may also include Wisconsin, will have to grapple with new Trump administration policies that make expansion more costly and logistically difficult, Politico reported. Also: The Trump administration OKs traditional healing for Native Americans in Utah's and Maine's Medicaid programs, yet the approval comes as it shrinks Medicaid in other ways.
Politico: Georgia, Kansas And Texas Eye Medicaid Expansion After Midterms Romp

Democrats are bullish on Medicaid expansion after seizing control of state legislative chambers and governors’ seats in some of the nation’s last remaining holdout states. “I’m hopeful that that is going to be one of the easier things that we get done,” said state Rep. Shea Roberts, a Georgia Democrat. She called expansion, which would cover non-disabled low-income adults without children who don’t qualify for traditional Medicaid, “low-hanging fruit” and “top of mind” for the party. (Ollstein, 11/17)

KFF Health News: Trump Administration OKs Native Traditional Healing For Two States’ Medicaid Programs

The Trump administration has approved two states’ requests to expand Medicaid to cover Native American traditional healing practices, even as it prepares to enforce rules that are expected to drop millions of people from the government health insurance program. Health and Human Services Secretary Robert F. Kennedy Jr. announced in September that the federal agency had approved traditional healing programs for Utah and Maine. The agency did so through waivers, which give a state permission to pay for certain programs that normally fall outside of Medicaid’s rules. (Orozco Rodriguez, 11/18)

On rural healthcare funding in Wyoming and Louisiana —

Wyoming Public Radio: Wyoming To Receive $207M For Rural Healthcare Next Year 

Wyoming will receive more than $207 million in federal funding to bolster rural health next year. It’s the second year disbursement from Congress’s five-year Rural Health Transformation Program, meant to improve healthcare and access nationwide. Wyoming’s award for 2027 is about $2 million more than what it received in 2026. (Merzbach, 11/17)

Verite News New Orleans: Louisiana Is Still Finalizing Rural Health Contracts

Money poured into Louisiana for health spending in rural areas this year, and the state made a mad dash to determine how to spend it. But it could be months before patients and providers see the effects. State agencies were given 10 months to design programs and award their first-year allocations from the Rural Health Transformation Program. The program is intended to offset the negative impacts of the 2025 budget package, also known as the “One Big Beautiful Bill Act,” which include cuts to Medicaid. (Parker, 11/17)

More health news from across the U.S. —

The Texas Tribune: Ken Paxton Drops Appeal In Texas Medical Board Lawsuit

Texas Attorney General Ken Paxton has withdrawn his legal support of a Houston doctor who was reprimanded after prescribing ivermectin to a COVID-19 patient at a hospital where she lacked privileges to practice medicine. (Langford, 11/17)

The Texas Tribune: Texas’ $3B Dementia Fund Languishes In Court A Year Later

From the get-go, the idea was a policy head-turner — a $3 billion research fund to solve a pressing healthcare issue in Texas, pitched by one of the state’s leading fiscal conservatives, Republican Lt. Gov. Dan Patrick. (Langford, 11/17)

Iowa Public Radio: S.A.F.E Center For Sexual Assault Survivors To Offer Services In Des Moines

A sexual assault care facility opening next week in Des Moines is the first of its kind in Iowa to offer both forensic examinations and medical treatment for victims of sexual violence. The S.A.F.E. Center of Iowa is located west of downtown, on the fourth floor of the DMU Clinic at the former Des Moines University campus. (Curran, 11/17)

The CT Mirror: New CT Therapeutic Arts Pavilion Breaks Ground: 'A Living Laboratory'

Clinicians at Silver Hill Hospital in New Canaan, who treat patients for psychiatric issues and substance abuse disorders, have watched the benefits of art and horticulture therapy up close for decades. On Tuesday, the hospital held a groundbreaking for a $3.5 million therapeutic arts pavilion that will transform an existing building and affirm its commitment to the creative arts and horticulture in its therapeutic milieu. (Tillman, 11/17)

ProPublica: California Regulators Blamed Brain Injuries Related To Six Flags’ X2 Roller Coaster On Riders

A 17-year-old boy died after riding the extreme X2 roller coaster at Six Flags Magic Mountain in California this summer, just weeks before two more people suffered severe brain injuries after riding the same attraction, ProPublica and L.A. Material have found. A homicide detective investigating Christopher Gibson’s death in June sent an email to the California official responsible for ensuring roller coaster safety. But records show that the official did not reply until nearly two months later. The lack of action raises the question of whether the brain damage suffered by the two riders the following month could have been avoided. (Rubin, 11/17)

Los Angeles Times: Sixth Central Coast Resident Confirmed With E. Coli, Nearly A Week After A Bacteria-Related Death

A sixth person in the Central Coast has been diagnosed with a complication from E. coli, a serious and, in some cases, fatal disease. This latest infected individual is believed to be linked to the larger bacterial outbreak that occurred in the area last month, which killed a toddler. San Luis Obispo County Public Health officials confirmed that the sixth person was infected with Shiga toxin-producing E. coli, also referred to as STEC, and was identified at a preschool in the city of San Luis Obispo. (Garcia, 11/17)

MedPage Today: Bird Flu Cases May Be Underreported In Washington Outbreak

Human cases of H5N1 avian influenza are likely going unreported amid an ongoing bird flu outbreak in Washington state, experts said. There have been 3 avian flu cases and one death in a patient with underlying health issues, according to Yakima County health officials. But a union representing farm workers said it believes the "official case numbers are a vast undercount." (Robertson, 11/17)

Health Industry

Financial Troubles Escalate At Illinois Hospital As State Denies $9M Request From Doctors

Vista Medical Center East in Waukegan will also soon be barred from receiving Medicare dollars, according to a notice Monday from CMS, the Chicago Tribune reported. Other industry news is on the Medicare Shared Savings Program, hospital antitrust lawsuits, and more.
Chicago Tribune: Illinois Rejects Request For More Money For Vista Hospital

Vista Medical Center East in Waukegan soon will be barred from receiving Medicare dollars, and the state will not grant doctors’ request for more money — developments that may push the troubled hospital closer to closure. (Schencker, 11/17)

More healthcare industry updates —

Fierce Healthcare: Medicare Shared Savings Program Saved $2.5B Last Year: CMS

The Medicare Shared Savings Program has reached the highest savings number in its history, according to new federal data. The Centers for Medicare & Medicaid Services said Tuesday that the program generated more than $2.5 billion in net savings to Medicare in 2025, making for the ninth year in a row that it led to cost savings. The agency added that every accountable care organization met or exceeded quality reporting requirements. (Minemyer, 11/17)

Modern Healthcare: Humana Launches Gold Card Prior Authorization Program

Humana has unveiled a new program to simplify prior authorization for qualifying providers. Beginning Dec. 1, the health insurance company will launch a “gold card” program allowing about 50,000 providers to use an expedited process for certain MRI, CT and MRA imaging, as well as physical and occupational therapy services. The program applies to 141 procedure codes across its individual Medicare Advantage and Dual Eligible Special Needs Plan, or D-SNP, business, a Humana spokesperson said. (Tepper, 11/17)

Modern Healthcare: Medline Bed Recall Tests Hospital-At-Home Programs

Medical equipment recalls are more complicated when the affected devices are in patients’ homes. A recent Medline brand bed recall is putting a spotlight on the challenges providers face in coordinating recall responses and replacing equipment in the home setting. The Medline beds, including home-care and long-term-care beds, were recalled in mid-October because of a potential fire hazard, according to a Food and Drug Administration notice. The beds’ electrical components could overheat under certain conditions, which could lead to hazards including electrical shock, burns or death. In addition, using the bed accessories could lead to entrapment or asphyxiation. (Dubinsky, 11/17)

Modern Healthcare: Hospital Antitrust Lawsuits Threaten Revenue, Contracts

Health systems could lose negotiating leverage as mounting antitrust litigation has led to more state and federal scrutiny of contracts that may limit competition between hospitals and insurers. Health system revenue could decline if organizations loosen contract terms targeted by the recent lawsuits, including anti-steering provisions that decrease access to lower-cost care options. While high-profile settlements have led to restrictions on anticompetitive contracting, those agreements are typically finite and may not spur change across the hospital sector, said Erin Fuse Brown, a health services, policy and practice professor at Brown University. (Kacik, 11/17)

North Carolina Health News and Charlotte Ledger: NC Hospital Execs See Double Digit Pay Raises From 2024 To 2025 

Gene Woods, CEO of Atrium Health parent Advocate Health, earned $28.3 million in 2025, a nearly 10 percent increase from the $25.8M he received in 2024, according to the health system’s latest federal tax filing. Woods wasn’t the only North Carolina hospital leader whose compensation increased. (Crouch, 11/18)

Also —

KFF Health News: Meet The Teen Who Called A Hospital Home

The teen’s hospital stay began in room 3005.The room didn’t feel like home at first. Back then, Jaloni didn’t have posters on the wall or snacks on the shelf, and he hadn’t learned about the morgue yet. He just wanted to survive. Fresh gunshot wounds filled the 14-year-old’s body with unbearable pain. That first night, Jaloni said, he could barely move. (Anthony, 11/18)

Politico: ‘Make It Happen:’ How Donors Wielded Influence On A Prestigious Medical School 

The money came with strings attached. As a condition of a $12.5 million donation, Mount Sinai’s Icahn School of Medicine in Manhattan agreed to christen a global health center after its benefactors: the Arnhold banking family. (Kaufman, 11/18)

MedPage Today: AI Writes Better Discharge Summaries Than Doctors, Study Suggests

Artificial intelligence (AI) outperformed clinicians in drafting hospital discharge summaries, a U.K.-based retrospective study showed. (Robertson, 11/17)

Editorials And Opinions

Viewpoints: First Political Battles Of 2027 Should Tackle Medicaid, RFK Jr. Impeachment; Measles Deaths Are A Preventable Tragedy

Opinion writers discuss these public health topics.
Bloomberg: Medicaid Expansion Will Be The First Big Political Fight Of 2027

November’s big Democratic wins in state races could empower the party to close the largest remaining gap in America’s healthcare safety net: Medicaid, the joint state-federal program providing healthcare for low-income Americans. Ten states have long refused to expand it, and Democrats have new power in several of them, including Texas, Georgia and Wisconsin. (Ronald Brownstein, 11/17)

Stat: Why Now Is The Time To Impeach HHS Secretary Robert Kennedy Jr. 

The midterms didn’t just bring a blue wave — it was a biomedical blue wave, with several doctors and scientists joining Congress. This moment presents a unique opportunity to remove a major American public health problem. I’m talking about impeaching Health and Human Services Secretary Robert F. Kennedy Jr. once the next Congress begins in January. (Paul Knoepfler, 11/18)

The New York Times: An Elegy For Americans Dying Of Measles 

America has officially lost its measles elimination status. (Perri Klass, 11/17)

CNN: Dr. Sanjay Gupta: Benefits Of Vaccines Are A Matter Of Fact 

I have started, scratched out and even abandoned the writing of this essay. I couldn’t do it. It wasn’t there. Didn’t feel it. Something kept nagging at me, and it took some time to finally figure out what it was. It’s the idea that this article would be labeled “opinion” or “editorial” in the first place. Sure, there are some topics that seem to lend themselves appropriately to opinion pages. Vaccines, however, which have prevented 6 million deaths every year worldwide and have fundamentally changed modern medicine, should not be on that list. (Dr. Sanjay Gupta, 11/17)

Stat: A Radical Way To Transform Medical Education 

Over eight years as an M.D./Ph.D. student, I have watched medical education change considerably. Preclinical curricula have become shorter, lectures have moved online, virtual reality tools have entered anatomy education, and licensing examinations have repeatedly changed. (Alex Serafini, 11/18)

Stat: Sellas Blood Cancer Immunotherapy Succeeds In Clinical Trial 

It looks like I was wrong about Sellas Life Sciences and its experimental blood cancer immunotherapy. On Tuesday, Sellas said the therapy, called galinpepimut-S, reduced the risk of death by 41% compared to standard treatment for patients with an advanced stage of acute myeloid leukemia (AML) — an outcome that achieved the main goal of a Phase 3 clinical trial, the company said. (Adam Feuerstein, 11/17)

Recent Morning Briefings

  • Today, November 18
  • Tuesday, November 17
  • Monday, November 16
  • Friday, November 13
  • Thursday, November 12
  • Tuesday, November 10
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF